Our Scleroderma Program

What is the role of National Jewish Health?

National Jewish Health is one of the world’s leaders in the study and management of immune diseases, such as scleroderma. National Jewish Health also specializes in Interstitial Lung Disease (ILD), a common lung abnormality of people with scleroderma. The National Institutes of Health has designated and funded National Jewish Health as a Specialized Center of Research for ILD.

Our healthcare providers have vast experience in treating people with scleroderma. We provide the expertise needed for the comprehensive evaluation and management of people with this disease. We aim to design an individualized treatment plan best suited for each person.

In addition, to provide comprehensive care for our patients with scerloderma, National Jewish Health provides physical, occupational and recreational rehabilitation services in our rehabilitation department.

For more information or to schedule an evaluation with one of our rheumatologists, call LUNG LINE® at 1-800-222-LUNG (5864).

This information has been approved by Aryeh Fischer, MD  (April 2008).